|
Synonyms: AOC 1001 | AOC-1001 | del-desiran
Compound class:
Nucleic acid
Comment: Delpacibart etedesiran (AOC 1001) is structurally a monoclonal antibody (mAb)-oligonucleotide conjugate (AOC) in which the mAb binds the transferrin receptor (TFRC;) for targeted delivery of a duplex small interfering RNA (siRNA) payload that degrades the mRNA that encodes DM1 protein kinase (DMPK) [1].
This entry provides information on the siRNA as the component that mediates the agent's intended pharmacodynamic effect. Further details about the parental anti-TFRC mAb are provided in the delpacibart entry. To improve pharmacokinetics and RNA binding the nucleotides in etedesiran are chemically modified (2'-O-methyl/2'-MOE monomers), with a mixed phosphorothioate/phosphate backbone. The mAb is attached to the siRNAs via malemide linkers at Cys-R positions on the passenger strands. Delpacibart etedesiran is proposed to reduce the global splicing defects that arise from toxic gain-of-function DMPK transcript accummulation in myocytes in myotonic dystrophy type 1. |
| References |
|
1. Johnson NE, Tai LJ, Hamel JI, Day JW, Statland JM, Soltanzadeh P, Subramony SH, Thornton CA, Arnold WD, Wicklund M et al.. (2026)
An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1. N Engl J Med, 394 (8): 763-772. [PMID:41707138] |